The American Cancer Society predicts that there will be about 164,100 new cases of lung cancer in the United States in the year 2000. Lung cancer is fairly rare in persons under the age of 40. The average age of persons found to have lung cancer is 60.
Non-small Cell Lung Cancer accounts for about 80% of all lung cancers.
Lung cancer is usually treated with a combination of modalities (i.e., surgery and chemotherapy and radiation) It is becoming more common to undergo a course of radiation or chemotherapy before surgery to reduce the number of cancer cells that may have the potential to spread.
Smoking is the single most important risk factor for the development of lung cancer. Persons who smoke cigarettes, pipes or cigars should consult with their health care provider about methods to quit as soon as possible.
A variety of complementary therapies have been used by persons with all types of cancer to reduce side effects of treatments such as nausea and pain. Biofeedback and other relaxation therapies as well as acupuncture have been used to reduce stress, anxiety and general discomfort.
This MediFocus Guide contains an extensive listing of citations and abstracts of recent journal articles that have been published about this condition in trustworthy medical journals. This is the same type of information that is available to physicians and other health care professionals. A partial selection of journal articles that are abstracted in this MediFocus Guide includes:
Evidence-based medicine in the treatment of non-small-cell lung cancer. Clinics in Chest Medicine. 2000
Innovative treatment strategies in locally advanced and/or unresectable non-small cell lung cancer. Cancer Control. 2000
Pathogenesis and management of respiratory insufficiency following pulmonary resection. Seminars in Surgical Oncology. 2000
Role of multimodality treatment for lung cancer. Seminars in Surgical Oncology. 2000
Combined modality therapy of non-small cell lung cancers. Annals of Oncology. 1999
Neoadjuvant and adjuvant trials in non-small cell lung cancer. Annals of Thoracic Surgery. 1998
Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patients. Chest. 2000
Unfavorable prognosis of patients with stage II non-small cell lung cancer associated with macroscopic nodal metastases. Chest. 1999
Relationship between quality of life and clinical outcomes in advanced non-small cell lung cancer: best supportive care (BSC) versus BSC plus chemotherapy. Lung Cancer. 1999
The prognosis of surgically resected N2 non-small cell lung cancer: the importance of clinical N status. Journal of Thoracic & Cardiovascular Surgery. 1999
MediFocus.com understands that consumers who are facing serious medical issues need access to credible, up-to-date medical information to help them make informed health-care decisions. That's why we've developed the MediFocus Guides...the most advanced and trustworthy patient research guides for over 200 chronic and life-threatening conditions. Each MediFocus Guide includes a detailed overview of the condition including information about diagnosis, treatment options, cutting-edge research, and new developments; excerpts of important journal articles from the current medical literature focusing on standard treatments and treatment options; a directory of leading authors and medical institutions who specialize in the treatment of the condition; and a listing of organizations and support groups where you can obtain additional information about the illness.
MediFocus Guides are the perfect solution for consumers who wish to gain an in-depth understanding of their medical issue and avail themselves of the same type of professional level medical information that is used by physicians and other health-care professionals to help then in the clinical decision making process.
